ConvaTec logo

CTEC - ConvaTec News Story

232p 1.5  0.7%

Last Trade - 07/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £4.65bn
Enterprise Value £5.35bn
Revenue £1.36bn
Position in Universe 198th / 1821

ConvaTec Group PLC - Annual Report and Accounts 2020 and Notice of AGM

Mon 22nd March, 2021 3:40pm
RNS Number : 0834T
ConvaTec Group PLC
22 March 2021
 

 

Annual Report and Accounts 2020 and

Notice of Annual General Meeting

 

                                    

READING, UNITED KINGDOM (22 March 2021) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a global medical products and technologies company, today announces that the following documents are now available on its website at www.convatecgroup.com.

 

-     Annual Report and Accounts 2020

-     Notice of 2021 Annual General Meeting

 

In compliance with Listing Rule 9.6.1, copies of the Annual Report and Accounts 2020 and Notice of 2021 Annual General Meeting will be submitted to the UK Listing Authority and will, in due course, be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Printed copies of these documents will be sent to shareholders who have requested hard copies in due course.

 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations &                                     +44 (0)7826 447807 

Corporate Communications, ConvaTec

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSFZGZFKZKGMZM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.